Published in Thorax on February 01, 2006
Interrelation Between Bronchial Asthma and Smoking | NCT03207620
The course of persistent airflow limitation in subjects with and without asthma. Respir Med (2008) 1.01
The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2013) 0.95
The irreversible component of persistent asthma. J Allergy Clin Immunol (2009) 0.86
Inhaled corticosteroids moderate lung function decline in adults with asthma. Thorax (2006) 0.85
Lost to follow-up in asthmatics does not mean treatment failure: causes and clinical outcomes of non-adherence to outpatient treatment in adult asthma. Allergy Asthma Immunol Res (2013) 0.83
The relation of airway obstruction to asthma, chronic rhinosinusitis and age: results from a population survey of adults. Allergy (2014) 0.81
Longitudinal changes in airway remodeling and air trapping in severe asthma. Acad Radiol (2014) 0.81
Inhaled Corticosteroids. Pharmaceuticals (Basel) (2010) 0.79
Revisiting early intervention in adult asthma. ERJ Open Res (2015) 0.75
Asthma worsenings: approaches to prevention and management from the Asthma Worsenings Working Group. Can Respir J (2009) 0.75
Effects of the recombinant allergen rDer f 2 on neuro-endocrino-immune network in asthmatic mice. Cent Eur J Immunol (2014) 0.75
The Danish National Database for Asthma: establishing clinical quality indicators. Eur Clin Respir J (2016) 0.75
Inhaled corticosteroids and long term outcome in adults with asthma. Thorax (2006) 0.75
Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT). NPJ Prim Care Respir Med (2016) 0.75
Longitudinal trends in clinical characteristics and lung function of patients with severe asthma under treatment in Brazil. BMC Pulm Med (2016) 0.75
Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med (2000) 8.32
Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med (2000) 5.82
Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J (2000) 5.54
Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet (2003) 5.10
Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med (1994) 4.76
Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med (1999) 4.65
A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med (1998) 4.52
Asthma and asthma-like symptoms in adults assessed by questionnaires. A literature review. Chest (1993) 4.22
Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med (1991) 4.09
Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (1999) 3.90
Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med (2000) 3.24
The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med (1987) 2.43
Rate of decline of lung function in subjects with asthma. Eur J Respir Dis (1987) 2.27
A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol (1992) 2.16
Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest (1995) 2.06
Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med (1994) 2.02
Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med (2001) 1.88
Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma. Thorax (2002) 1.81
Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study. Am J Respir Crit Care Med (1999) 1.52
Asthma, asthmalike symptoms, chronic bronchitis, and the degree of bronchial hyperresponsiveness in epidemiologic surveys. Am Rev Respir Dis (1987) 1.41
Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med (1994) 1.36
Adult patients may outgrow their asthma: a 25-year follow-up study. Am J Respir Crit Care Med (1997) 1.31
Persistence of airway obstruction and hyperresponsiveness in subjects with asthma remission. Chest (1994) 1.23
Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax (1996) 1.21
Outcome of asthma: longitudinal changes in lung function. Eur Respir J (1999) 1.15
Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma. Eur Respir J (1999) 1.13
Pharmacotherapy and airway remodelling in asthma? Thorax (2003) 1.11
Is airway remodeling clinically relevant in asthma? Am J Med (2003) 0.99
Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 4.74
A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med (1998) 4.52
Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J (2002) 4.01
Developing COPD: a 25 year follow up study of the general population. Thorax (2006) 3.72
Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ (1998) 3.45
Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisited. Eur Respir J (2008) 3.36
Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J (1997) 3.29
Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J (2002) 3.22
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax (2005) 2.69
Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J (2005) 2.51
Epidemiology of chronic obstructive pulmonary disease. Eur Respir J (2001) 2.43
Coronary heart disease risk factors ranked by importance for the individual and community. A 21 year follow-up of 12 000 men and women from The Copenhagen City Heart Study. Eur Heart J (2002) 2.16
Smoking reduction, smoking cessation, and incidence of fatal and non-fatal myocardial infarction in Denmark 1976-1998: a pooled cohort study. J Epidemiol Community Health (2003) 2.13
Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J (2009) 2.11
COPD-related morbidity and mortality after smoking cessation: status of the evidence. Eur Respir J (2008) 2.06
A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. Am J Respir Crit Care Med (1999) 1.99
Recommendations for epidemiological studies on COPD. Eur Respir J (2011) 1.84
Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12 149 men and women in The Copenhagen City Heart Study. J Epidemiol Community Health (2002) 1.82
Life expectancy in Danish women and men related to smoking habits: smoking may affect women more. J Epidemiol Community Health (1998) 1.80
Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.78
Prevalence and prognosis of electrocardiographic left ventricular hypertrophy, ST segment depression and negative T-wave; the Copenhagen City Heart Study. Eur Heart J (2002) 1.74
The natural history of chronic obstructive pulmonary disease. Eur Respir J (2006) 1.66
Risk of malignant neoplasms in patients with pulmonary sarcoidosis. Thorax (1997) 1.62
Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J (2002) 1.60
Socioeconomic status and chronic obstructive pulmonary disease. Thorax (1999) 1.60
Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study. Thorax (2002) 1.59
Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study. Eur Respir J (1999) 1.56
Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J (1995) 1.52
Mortality in women and men in relation to smoking. Int J Epidemiol (1998) 1.52
Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study. Eur Respir J (2011) 1.47
Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies. Thorax (2010) 1.46
Potential misclassification of causes of death from COPD. Eur Respir J (2006) 1.42
Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders. Thorax (2008) 1.34
Stress and life dissatisfaction are inversely associated with jogging and other types of physical activity in leisure time--The Copenhagen City Heart Study. Scand J Med Sci Sports (2005) 1.28
Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. Eur Respir J (2003) 1.28
Social position and mortality from respiratory diseases in males and females. Eur Respir J (2003) 1.26
Measuring bronchodilation in COPD clinical trials. Br J Clin Pharmacol (2005) 1.24
Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach. Eur Respir J (2010) 1.23
Chronic obstructive pulmonary disease in patients admitted with heart failure. J Intern Med (2008) 1.17
Outcome of asthma: longitudinal changes in lung function. Eur Respir J (1999) 1.15
Gender and smoking-related risk of lung cancer. The Copenhagen Center for Prospective Population Studies. Epidemiology (1998) 1.15
Multivariate genetic analysis of atopy phenotypes in a selected sample of twins. Clin Exp Allergy (2006) 1.15
Mortality in adults with self-reported asthma. Copenhagen City Heart Study Group. Lancet (1996) 1.14
Predictors of smoking reduction and cessation in a cohort of danish moderate and heavy smokers. Prev Med (2001) 1.12
Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease. Eur Respir J (2005) 1.10
The International Journal of Tuberculosis and Lung Disease--a home for respiratory epidemiology. Int J Tuberc Lung Dis (1998) 1.08
Peak flow as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.06
Risk factors for death and hospitalization from pneumonia. A prospective study of a general population. Eur Respir J (1995) 1.05
Increased T-regulatory cells within lymphocyte follicles in moderate COPD. Eur Respir J (2009) 1.05
Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage. Eur Respir J (1993) 1.04
The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality. J Intern Med (2007) 1.04
Prognostic value of interleukin-8 in AIDS-associated Pneumocystis carinii pneumonia. Am J Respir Crit Care Med (1995) 1.04
Exogenous female sex steroid hormones and risk of asthma and asthma-like symptoms: a cross sectional study of the general population. Thorax (2001) 1.00
Patient-administered sequential spirometry in healthy volunteers and patients with alpha 1-antitrypsin deficiency. Respir Med (1996) 0.99
Is diastolic hypertension an independent risk factor for stroke in the presence of normal systolic blood pressure in the middle-aged and elderly? Am J Hypertens (1997) 0.98
Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals. Clin Chem (2001) 0.97
Increase in prevalence and severity of asthma in young adults in Copenhagen. Thorax (2000) 0.97
Bronchodilator reversibility in COPD: the roguish but harmless little brother of airway hyperresponsiveness? Eur Respir J (2005) 0.97
Candidate genes for COPD in two large data sets. Eur Respir J (2010) 0.96
Distribution of serum IgE in children and adolescents aged 7 to 16 years in Copenhagen, in relation to factors of importance. Allergy (1992) 0.95
Association between obesity and asthma in a twin cohort. Allergy (2007) 0.94
Familial predisposition and susceptibility to the effect of other risk factors for myocardial infarction. J Epidemiol Community Health (1999) 0.94
Chronic obstructive pulmonary disease as a systemic disease: an epidemiological perspective. Eur Respir J Suppl (2003) 0.94
A comparison of mortality rates in three prospective studies from Copenhagen with mortality rates in the central part of the city, and the entire country. Copenhagen Center for Prospective Population Studies. Eur J Epidemiol (1998) 0.93
Very low level of microalbuminuria is associated with increased risk of death in subjects with cardiovascular or cerebrovascular diseases. J Intern Med (2006) 0.93
Isolated systolic hypertension as a major risk factor for stroke and myocardial infarction and an unexploited source of cardiovascular prevention: a prospective population-based study. J Hum Hypertens (1995) 0.91
Development, dimensions, reliability and validity of the novel Manchester COPD fatigue scale. Thorax (2009) 0.91
Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study. Eur Respir J (2009) 0.91
Lung function after allogeneic bone marrow transplantation for leukaemia or lymphoma. Arch Dis Child (1996) 0.90
Prevalence and severity of self-reported asthma in young adults, 1976-2004. Eur Respir J (2009) 0.90
Published models and local data can bridge the gap between reference values of lung function for children and adults. Eur Respir J (1997) 0.90
The association between aortic augmentation index and cardiovascular risk factors in a large unselected population. J Hum Hypertens (2011) 0.89
Does cytomegalovirus predict a poor prognosis in Pneumocystis carinii pneumonia treated with corticosteroids? A note for caution. Chest (1995) 0.88
Bronchial responsiveness to exercise in a random sample of 494 children and adolescents from Copenhagen. Clin Exp Allergy (1992) 0.88
Changes in smoking habits and risk of asthma: a longitudinal population based study. Eur Respir J (2001) 0.85
Findings on the atopic triad from a Danish twin registry. Int J Tuberc Lung Dis (2006) 0.84
Prevalence and predictors of atopy among young Danish adults. Clin Exp Allergy (2002) 0.84
Atopy and bronchial responsiveness in random population sample of 527 children and adolescents. Ann Allergy (1992) 0.84
Effect of treatments on the progression of COPD: report of a workshop held in Leuven, 11-12 March 2004. Thorax (2005) 0.83
Methods for therapeutic trials in COPD: lessons from the TORCH trial. Eur Respir J (2009) 0.83
Highly significant linkage to chromosome 3q13.31 for rhinitis and related allergic diseases. J Med Genet (2006) 0.83
Clinical characteristics and airway inflammation profile of COPD persistent sputum producers. Respir Med (2014) 0.82
An 8-year follow-up study of pulmonary function in patients with rheumatoid arthritis. Rheumatol Int (1994) 0.82
Interleukin-8 and leukotriene B4 in bronchoalveolar lavage fluid from HIV-infected patients with bacterial pneumonia. Respir Med (1997) 0.81
Risk factors for asthma in young adults: a co-twin control study. Allergy (2006) 0.81
Significant linkage to chromosome 12q24.32-q24.33 and identification of SFRS8 as a possible asthma susceptibility gene. Thorax (2006) 0.81
CD8 chemokine receptors in chronic obstructive pulmonary disease. Clin Exp Immunol (2008) 0.80
Association of PTGDR gene polymorphisms with asthma in two Caucasian populations. Genes Immun (2007) 0.80
Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease. The Danish Society of Respiratory Medicine. Respir Med (1999) 0.80
Use of different exhaled nitric oxide multiple flow rate models in COPD. Eur Respir J (2007) 0.80
Cardiovascular risk factor profile in subjects with familial predisposition to myocardial infarction in Denmark. J Epidemiol Community Health (1997) 0.79
The pathophysiological role of mucus production in inflammatory airway diseases. Respir Med (1995) 0.79
Level of FEV1 as a predictor of all-cause and cardiovascular mortality: an effect beyond smoking and physical fitness? Eur Respir J (2005) 0.78
Penicillin as empirical therapy for patients hospitalised with community acquired pneumonia at a Danish hospital. Dan Med Bull (2001) 0.78
Outcomes in elderly Danish citizens admitted with community-acquired pneumonia. Regional differencties, in a public healthcare system. Respir Med (2012) 0.78
COPD in the ECRHS. Thorax (2004) 0.78